Skip to main content

Table 5 Percent distribution of Active Pharmaceutical Ingredient (API) in purchased ampoules of oxytocin and methylergometrine, by district

From: Accessibility and potency of uterotonic drugs purchased by simulated clients in four districts in India

  Karnataka state Uttar Pradesh state
  Bagalkot Hassan Agra Gorakhpur
% API OXYTOCIN (%) METHYL-ERGOMETRINE (%) OXYTOCIN (%) METHYL-ERGOMETRINE (%) OXYTOCIN (%) METHYL- ERGOMETRINE (%) OXYTOCIN (%) METHYL- ERGOMETRINE (%)
0%-25% 0.0 0.0 8.9 0.0 2.0 2.0 0.0 2.0
26-50% 0.0 9.5 2.2 0.0 6.0 2.0 0.0 0.0
51%-75% 4.2 7.1 4.4 13.0 14.0 8.0 2.0 6.0
76%-89% 27.1 83.3 22.2 82.6 16.0 42.0 10.0 36.0
WITHIN MANU-FACTURER SPECIFICA-TION (90%-110%) 66.7 0.0 60.0 4.3 50.0 46.0 78.0 56.0
111%-120% 2.1 0.0 2.2 0.0 12.0 0.0 8.0 0.0
Missing data 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0
TOTAL 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
% Out of specification 33.0 100.0 40.0 95.7 50.0 54.0 22.0 44.0
Median API 98.5 84.4 98.7 85.8 99.0 89.2 102.9 90.4
N of ampoules of analysis 48 42 45 46 50 50 50 50